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Lymphocyte development occurs in a stepwise progression through dis-
tinct developmental stages. This ordered 
maturation ensures that cells express a 
single, non-autoreactive antigen recep-
tor, which is the cornerstone of a diverse 
adaptive immune response. Expression 
of a mature antigen receptor requires 
assembly of the antigen receptor genes 
by the process of V(D)J recombination, a 
reaction that joins distant gene segments 
through DNA double-strand break 
(DSB) intermediates. These physiologic 
DSBs are generated by the recombinase-
activating gene (RAG) -1 and -2 proteins, 
and their generation is regulated by lym-
phocyte and developmental stage-spe-
cific signals from cytokine receptors and 
antigen receptor chains. Collectively, 
these signals ensure that V(D)J recom-
bination of specific antigen receptor 
genes occurs at discrete developmental 
stages. Once generated, RAG-induced 
DSBs activate the ataxia-telangiectasia 
mutated (ATM) kinase to orchestrate a 
multifaceted DNA damage response that 
ensures proper DSB repair. In response 
to RAG DSBs, ATM also regulates a cell 
type-specific transcriptional response, 
and here we discuss how this genetic pro-
gram integrates with other cellular cues 
to regulate lymphocyte development.
Introduction
Lymphocytes proceed through discrete 
stages as they develop into mature B and T 
cells. Lymphocyte-specific, stage-specific 
and lineage-specific signals direct differ-
entiation to ensure that each cell uniquely 
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expresses the appropriate antigen receptor 
genes at the correct developmental stage. 
These signals culminate in the assembly 
of functional antigen receptor genes and 
expression of a non-autoreactive antigen 
receptor. The second exon of all antigen 
receptor genes must be assembled from 
variable (V), joining (J) and, at some loci, 
diversity (D) gene segments.1 These dis-
tinct gene segments are joined through 
the generation and repair of DNA breaks. 
This process of V(D)J recombination is 
initiated by the recombinase-activating 
genes, RAG1 and RAG2, which encode 
proteins that, together, form the RAG 
endonuclease.2-4 RAG binds to recombi-
nation signals, specific DNA sequences, 
at the border of the V, D and J segments 
and generates DNA double-strand breaks 
(DSBs).2-4 These RAG DSBs are pro-
cessed and joined by the non-homologous 
end-joining (NHEJ) pathway of DNA 
DSB repair.5-7
In developing B lymphocytes, the 
heavy chain (IgH) gene is rearranged first 
at the pro-B cell stage and is expressed 
in conjunction with the surrogate light 
chains (VpreB and λ5) to form the pre-
BCR.8 Expression of the pre-BCR signals 
transition to the pre-B cell developmental 
stage.8 Pre-B cells subsequently assemble a 
functional light chain (IgL) gene at either 
the kappa (IgLκ) or lambda (IgLλ) locus.9 
The ordered rearrangement of IgH and 
IgL genes is regulated by diverse cellular 
signals.
In pre-B cells, the interleukin-7 
receptor (IL-7r) and the pre-BCR are 
the principal regulators of cell prolifera-
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cells and prevents generation of RAG 
DSBs at antigen receptor loci in actively 
dividing cells.
Activation of the IL-7r in pre-B cells 
leads to phosphorylation and dimeriza-
tion of STAT5, which results in nuclear 
translocation and initiation of gene 
expression.10,45,46 STAT5 mediates the 
upregulation of anti-apoptotic and prolifer-
ation genes, including Bcl2, Bcl-X
L
, Mcl-1 
and Pim-1, CCND2 (cyclin-D2) and 
CCND3 (cyclin-D3).10,45,46 Additionally, 
STAT5 coordinates increased accessibility 
of the IgH locus and simultaneous inacti-
vation of the IgL locus, thereby preventing 
light chain recombination.46-48
The IL-7r also phosphorylates and acti-
vates the Akt (PKB) kinase, which coop-
erates with STAT5 signaling to support 
pre-B cell survival at least in part through 
phosphorylation and inactivation of the 
pro-apoptotic protein BAD.10,31,49 Akt also 
phosphorylates the FoxO1 and FoxO3a 
transcription factors resulting in their 
cytoplasmic retention and inactivation.50-53 
Attenuation of IL-7 signals disables Akt 
and stabilizes the FoxO transcription fac-
tors, resulting in expression of RAG and 
activation of IgL gene rearrangement.50-53 
As such, loss of IL-7 signals is necessary 
for IgL chain gene assembly, but the con-
comitant loss of survival signals would be 
detrimental to pre-B cells.
Pre-BCR Signaling
Ligand-independent oligomerization of 
the pre-BCR promotes pathways that par-
ticipate in the regulation of cellular prolif-
eration, allelic exclusion of the IgH chain 
gene and activation of IgLκ chain gene 
rearrangement.8,54-56 The pre-BCR signals 
through the Igα and Igβ subunits to acti-
vate multiple downstream pathways.8,54 
Activation of the RAS kinase triggers a 
kinase cascade that includes MEK to ERK 
activation, which leads to expression of the 
Aiolos transcriptional repressor and the 
E2A transcription factor.48 Aiolos inhibits 
expression of CCND3 (cyclin-D3) to sup-
port cell cycle arrest, while E2A activates 
transcription of the IgLκ chain genes.48 
Additionally, pre-BCR signals support 
PI3K-Akt signaling, thus, augmenting 
IL-7r signaling through this pathway to 
suppress FoxO transcriptional activity and 
RAG DSBs Activate a Unique 
Transcriptional Program
In addition to signals important in DSB 
repair, RAG DSBs also activate programs 
that regulate broader cellular responses. 
Similar to genotoxic DSBs, in response 
to RAG DSBs, ATM phosphorylates the 
transcription factor p53, resulting in its 
stabilization and increased transcriptional 
activity.31-35 Once activated, p53 regulates 
the expression of numerous cell cycle and 
cell death genes, including p21, PUMA, 
NOXA and BAX.33,36 Deficiency of p53 
results in a higher incidence of lymphoid 
malignancies with chromosomal translo-
cations, consistent with an important role 
for this tumor suppressor in eliminating 
cells at risk for aberrant DNA repair and 
malignant transformation.33,37-41 However, 
mechanisms must exist to ensure that 
p53 does not induce the death of all cells 
attempting to assemble antigen receptor 
genes.
Indeed, RAG DSBs trigger NFκB-
dependent transcription, which regu-
lates expression of a genetic program that 
includes survival genes.31,42 The dual regu-
lation of survival and cell death pathways 
by RAG DSBs is temporally balanced, 
allowing time for proper assembly of the 
antigen receptor genes, but ensuring elimi-
nation of cells with persistent DSBs at risk 
for errant repair. These opposing processes 
may enforce normal development and sup-
press malignant transformation. Moreover, 
RAG DSBs initiate expression of lympho-
cyte-specific cellular programs that inte-
grate with other developmental cues in 
pre-B cells, including those initiated by the 
IL-7r and pre-BCR, and support lympho-
cyte differentiation and maturation.42
IL-7r Signaling in Pre-B Cells
IL-7 signaling is critical for early lym-
phocyte development, as evidenced by 
the block in B and T cell maturation at 
early stages in mice deficient in IL-7 or 
the IL-7r.10,43,44 In pre-B cells, the IL-7r 
signals through both the JAK-STAT and 
the PI3K-Akt pathways to support cell 
survival and proliferation while simulta-
neously suppressing IgL gene accessibility 
and RAG expression.10 In this manner, 
IL-7 induces clonal expansion of pre-B 
signals cooperate to regulate accessibil-
ity of the antigen receptor genes, RAG 
expression and transcriptional programs 
necessary for cell type-specific differen-
tiation.8,10 In addition to these cell surface 
receptors, recent studies have shown that 
signals from RAG DNA breaks activate 
genetic programs that have important 
consequences for developing lymphocytes. 
Here we review how these DSB-dependent 
signals are integrated with other signals 
that drive lymphocyte development and 
differentiation.
RAG DSBs Activate Canonical 
DNA Damage Responses
RAG DSBs are generated in the G
1
 phase 
of the cell cycle as RAG2 is phosphorylated 
and degraded upon entry into S-phase.12 
Similar to other DSBs generated in G
1
, 
RAG DSBs trigger canonical DNA dam-
age responses through activation of ATM 
and DNA-PKcs, which are both mem-
bers of the phosphatidylinositol-3-kinase 
(PI3K)-like family of serine-threonine 
kinases.5-7 Both ATM and DNA-PKcs 
function as transducers in the DNA dam-
age response to phosphorylate numerous 
downstream effectors.13-16
ATM and DNA-PKcs have unique 
and redundant roles in response to RAG-
mediated DSBs.5,17,18 Deficiency of either 
of these kinases results in errors in repair 
of the broken DNA ends and immune 
deficiencies in mice and humans.5,7,19-23 
Following induction of RAG DSBs, 
ATM is responsible for promoting the sta-
bility of the broken DNA (coding) ends 
in a post-cleavage complex until they are 
joined.24 DNA-PKcs promotes the activ-
ity of the Artemis endonuclease, which is 
required to open hairpin-sealed ends gen-
erated by the RAG endonuclease.15,25,26 
These kinases function in conjunction 
with other NHEJ proteins to ensure 
proper repair of RAG DSBs.5-7 Moreover, 
ATM phosphorylates the histone variant 
H2AX (γ-H2AX) for several kilobases 
surrounding DNA breaks, including RAG 
DSBs.27-29 Phosphorylated H2AX recruits 
proteins to the site of the DNA break, 
amplifying DNA damage responses and 
supporting normal DSB repair, including 
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concomitant loss of Pim1 and Akt survival 
signals with rapid induction of cell death 
mechanisms.10,31,53,61,62 However, shortly 
after their generation during IgL chain 
gene assembly, RAG DSBs upregulate 
influenced by intrinsic signals triggered 
by the DSBs generated during IgL chain 
gene rearrangement. Initiation of IgL 
chain gene assembly requires the attenu-
ation of IL-7 signaling, which results in 
inhibit RAG expression.50,51 The pre-BCR 
complex also activates SLP-65 (BLNK), 
which further augments Aiolos expres-
sion and upregulates expression of IRF4, 
another important regulator of IgLκ tran-
scription.57,58 Pre-BCR signals have also 
been demonstrated to promote prolifera-
tion in conditions of low IL-7 concentra-
tions and to upregulate expression of the 
chemokine receptor CXCR4, which pro-
motes migration of pre-B cells to distinct 
bone marrow compartments in response 
to its ligand CXCL12.8,58
Integration of IL-7 receptor  
and pre-BCR signals
The IL-7r and the pre-BCR combine 
to provide signals necessary for ongo-
ing B cell maturation. The integration of 
these signaling pathways controls pre-B 
cell proliferation, survival and IgL chain 
gene recombination.8,10,11 IL-7r signals 
promote cell proliferation while simulta-
neously suppressing RAG expression and 
IgLκ chain gene accessibility.10,53,58 These 
signals must be attenuated for continued 
differentiation. Pre-BCR signaling may, 
in part, regulate IL-7 signaling through 
downregulation of IL-7r expression.59,60 
Moreover, pre-BCR signals upregulate 
CXCR4 expression, which can promote 
cell migration in response to CXCL12 to 
bone marrow microenvironments that are 
devoid of IL-7-producing stromal cells.58 
As IL-7 diminishes, PI3K-Akt signaling 
ceases, resulting in activation of FoxO 
transcription factors and expression of the 
RAG machinery.53 Additionally, loss of 
IL-7 signals triggers increased expression 
of SLP-65 (BLNK) and Syk, two critical 
intracellular signaling components of the 
pre-BCR, which, in turn, activate Aiolos 
and IRF4 expression to suppress prolif-
eration and activate IgLκ transcription, 
respectively.53,57,58 In this manner, the 
IL-7r and the pre-BCR cooperate to con-
trol RAG expression, IgLκ accessibility 
and B cell maturation.
Regulation of Lymphocyte  
Developmental Processes by RAG 
DSB Signaling
In addition to the extrinsic signals from 
the IL-7r and pre-BCR, pre-B cells are also 
Figure 1. integration of surface receptor signals and DNa damage responses in pre-B cells. in de-
veloping pre-B cells, signals from the iL-7r, pre-BCr and raG DSBs coordinate to direct continued 
maturation. in large pre-B cells, iL-7r and pre-BCr signals support proliferation and survival to 
optimize clonal expansion of igH-expressing cells. this proliferation phase occurs in bone marrow 
niches rich in iL-7-producing cells. iL-7r signals through Stat5 and akt to maintain proliferation 
and survival. additionally, Stat5 supports igH chain gene transcription and suppresses igL chain 
gene accessibility while akt inhibits raG expression. Pre-BCr signals support akt signaling dur-
ing this expansion phase. attenuation of iL-7r signaling, which may be mediated by migration of 
pre-B cells to bone marrow niches devoid of iL-7-producing cells, results in transition to the small 
pre-B cell developmental stage. Loss of iL-7 results in termination of Stat5 signals and associated 
cell cycle arrest. the cessation of akt activity results in stabilization of FoxO transcription factors 
and expression of raG and SLP-65. SLP-65 redirects pre-BCr signaling to expression of irF4 and 
transcription of igL chain genes, which permits igL locus accessibility to raG. raG DSBs trigger 
atM-dependent DNa damage responses (DDr), which intersect with pre-BCr signals to promote 
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Concluding Remarks
All lymphocytes generate DSBs as they 
assemble functional antigen receptor genes 
at different developmental stages. The 
specific antigen receptor genes that are 
rearranged and the timing of the DSBs 
generation are regulated by surface recep-
tor signals, such as those from the IL-7r and 
the pre-BCR in developing B cells. These 
external cellular cues trigger pathways that 
control (1) accessibility of antigen recep-
tor genes to transcriptional machinery, (2) 
RAG recombinase expression and (3) cell 
proliferation and survival. In large, pre-B 
cells, IL-7r and pre-BCR signals cooperate 
to promote survival, proliferation and clonal 
expansion while suppressing RAG expres-
sion and IgL chain gene accessibility (Fig. 
1). To continue maturation and transition 
to the small pre-B cell stage, IL-7r signaling 
must be attenuated, which occurs, at least 
in part, through migration away from IL-7-
producing stromal cells. Loss of IL-7 signals 
results in expression of RAG, IgL germline 
transcription and modification of pre-BCR 
signaling. Once generated, the RAG DSBs 
themselves trigger a DNA damage response 
that activates a unique lymphocyte-specific 
program, which intersects with IL-7r and 
antigen receptor signals to direct lympho-
cyte differentiation. In this regard, RAG 
DSBs and the pre-BCR regulate pathways 
to suppress the proliferative response to IL-7 
and likely promote pre-B cell residence in 
bone marrow niches devoid of IL-7 (Fig. 1). 
Together, these mechanisms maintain G
1
 
arrest in cells undergoing IgL recombina-
tion. Simultaneously, RAG DSBs activate 
survival mechanisms to replace loss IL-7-
driven survival signals, permitting time for 
repair of the broken DNA ends and expres-
sion of a functional IgL chain gene. The 
integration of these DNA damage responses 
with extrinsic development cues creates a 
coordinated signaling network to man-
age DNA breaks, enforce normal lympho-
cyte development and suppress malignant 
transformation.
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signaling and maintain cell cycle arrest. 
In this regard, DNA damage responses 
and antigen receptor signals cooperate 
to prevent pre-B cells with RAG DSBs 
from entering S-phase, where these DNA 
breaks could be repaired as translocations 
or as replicated broken chromosomes.
In pre-B cells RAG DSBs also induce 
expression of genes with known functions 
in lymphocyte migration and homing 
such as CD69, L-selection (CD62L) and 
SWAP-70.42,68-72 SWAP-70 and L-selectin 
regulate integrin-mediated adhesion and 
chemokine responses, respectively, to 
control lymphocyte homing to secondary 
lymphoid organs.69,70,73,74 CD69 mediates 
downregulation of the S1P1 receptor, 
which binds to sphingosine-1-phosphate 
(S1P) and promotes egress of lympho-
cytes out of the thymus and other sec-
ondary lymphoid organs.71,72 The S1P1 
receptor is also required to promote the 
migration of newly generated B cells 
from the bone marrow.75,76 Expression of 
CD69 blocks S1P1 receptor expression 
in immature B cells and prevents their 
migration into the periphery.75 Thus, the 
induction of CD69 by RAG DSBs may 
prevent pre-B cells from exiting the bone 
marrow prior to completing IgL chain 
gene assembly. Moreover, expression of 
CD69, SWAP-70 and L-selectin by RAG 
DSBs may function in conjunction with 
signals from the pre-BCR, which pro-
mote CXCR4 expression and migration 
away from IL-7-producing stromal cells.58 
In this regard, the combination of anti-
gen receptor and DSB-dependent signals 
could promote the residence of pre-B cells 
in bone marrow compartments devoid 
of IL-7 while they complete assembly of 
the IgL chain genes and expression of a 
mature BCR.
Interestingly, regulation of develop-
mental programs by physiologic DSBs 
is also observed during later stages of 
B cell development in the spleen. The 
DNA DSBs generated during class switch 
recombination in mature B cells promote 
a transcriptional program that controls 
differentiation of activated B cells into 
plasma cells.77,78 Thus, signals from physi-
ologic DSBs regulate cell type-specific 
genetic programs that function at various 
stages of lymphocyte development to pro-
mote normal immune cell maturation.
expression of Pim2, a member of a fam-
ily of pro-survival kinases that includes 
Pim1 and Akt.31,42,63 Upregulation of 
Pim2 provides a cytokine-independent 
survival signal through maintenance of 
the phosphorylation and inactivation of 
BAD, which promotes increased levels of 
Bcl2.31,36 This early survival signal coun-
ters p53-associated cell death mecha-
nisms, allowing time for proper repair of 
RAG DSBs and assembly of a functional 
IgL chain gene.
Pre-B cells frequently must undergo 
several successive IgL chain gene re-
arrangements, each of which can take sev-
eral hours to complete. Thus, pre-B cells 
need to survive for an extended period 
of time as they attempt to assemble and 
express a functional IgL chain gene.64 
Indeed, Pim2-deficient mice have fewer 
IgLλ-expressing B cells, consistent with 
reduced pre-B cell survival and time 
to complete IgL chain gene rearrange-
ment.31,65 The pro-survival functions of 
Pim2 replace lost IL-7 survival signals to 
counter cell death mechanisms and pro-
vide optimal opportunity for completion 
of IgL chain gene assembly. Importantly, 
if DSBs cannot be repaired, cell death 
pathways overcome the early survival sig-
nals to eliminate cells at risk of aberrant 
DSB repair, such as translocations. Thus, 
expression of Pim2 by RAG DSBs results 
in a temporal ordering of early survival 
followed by late cell death mechanisms, 
which promotes normal lymphocyte 
development while suppressing malignant 
transformation.
In striking contrast to the pro-pro-
liferative properties of Pim1 and Akt 
downstream of IL-7, expression of Pim2 
by RAG DSBs inhibits IL-7-driven pro-
liferation.31,66,67 The mechanisms under-
lying the anti-proliferative properties of 
Pim2 are unclear. Notably, though, Pim2 
is not sufficient to block proliferation 
but functions in conjunction with other 
DSB-dependent checkpoint activators to 
maintain cell cycle arrest.31 This unique 
function of Pim2 in cells undergoing 
V(D)J recombination may be important 
to help enforce the G
1
 to S checkpoint in 
the presence of low levels of IL-7. As such, 
the anti-proliferative function of Pim2 
downstream of RAG DSBs may integrate 
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